Sitagliptin-Metformin-Mepha retard 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung

7680690330019 CH-69033 Tabletten mit veränderter Wirkstofffreisetzung
Sitagliptin-Metformin-Mepha retard 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
Sitagliptin-Metformin-Mepha retard 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
Sitagliptin-Metformin-Mepha retard 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Tablette(n)
Galenic form
Tabletten mit veränderter Wirkstofffreisetzung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/07/2026
Patient information leaflet
Français
25/07/2026
Patient information leaflet
Italien
25/07/2026
Summary of Product Characteristics
Allemand
25/07/2026
Summary of Product Characteristics
Français
25/07/2026
Summary of Product Characteristics
Italien
25/07/2026

Detailed composition

Substance Quantity Type Category
sitagliptinum
50.0 MG Substance Wirkstoff (Principe actif)
sitagliptini hydrochloridum monohydricum
- Substance WIZUS
metformini hydrochloridum
500.0 MG Substance Wirkstoff (Principe actif)
hypromellosum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
calcii hydrogenophosphas
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
E 171
- Substance FNIDK
macrogolum 4000
- Substance HNIDK
talcum
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
natrium
2.147 MG Substance HBESI

Reimbursement information

Public price
CHF 33.10
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2023

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
69033
Drug name
Sitagliptin-Metformin-Mepha retard, Tabletten mit veränderter Wirkstofffreisetzung
Galenic form
TABWF
ATC Code
A10BD07
Authorization status
Z
Dispensing category
B
First authorization
18/04/2023
Authorization expiration date
17/04/2028
IT Number
07.06.2.
Domain
Human medicine
Field of application
Diabetes mellitus Typ 2

Package details

Description (FR)
SITAGLIPTIN Metform Mepha retard 50/500mg 60 pce
Description (DE)
SITAGLIPTIN Metform Mepha retard 50/500mg 60 Stk
Market launch
18/04/2023
Narcotic (BTM)
No

Original drug

Janumet, Filmtabletten
GTIN: 7680584500016
CHF 41.30
View original

Other package sizes (5)

SITAGLIPTIN Metform Mepha retard 50/500mg 160 pce
160 TABL
GTIN: 7680690330026
View
SITAGLIPTIN Metform Mepha retard 50/1000mg 60 pce
60 TABL
GTIN: 7680690330033
View
SITAGLIPTIN Metform Mepha retard 50/1000mg 160 pce
160 TABL
GTIN: 7680690330040
View
SITAGLIPTIN Metform Mepha retard 100/1000mg 30 pce
30 TABL
GTIN: 7680690330057
View
SITAGLIPTIN Metform Mepha retard 100/1000mg 90 pce
90 TABL
GTIN: 7680690330064
View
Buy us a coffee Explore the data